お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
989827

体外診断品質管理市場規模調査:提供別、用途別、ディストリビューター別、エンドユーザー別(~2026年)、COVID-19の累積的影響

In-Vitro Diagnostics Quality Control Market Research Report by Offering, by Distributor, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.46円
体外診断品質管理市場規模調査:提供別、用途別、ディストリビューター別、エンドユーザー別(~2026年)、COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の体外診断品質管理の市場規模は2020年の10億9599万米ドルから2025年末までに14億8089万米ドルに成長すると予想されています。

当調査は、体外診断品質管理の世界市場を分類して、収益を予測し、次の各サブマーケットの動向を分析します。

提供別だと、データ管理ソリューション、品質保証サービス、および品質管理製品にわたって体外診断品質管理市場は調査されました。

用途別だと、臨床化学、凝固または止血、血液学、免疫化学、微生物学、および分子診断にわたって調査されました。

ディストリビューター別だと、OEMおよびサードパーティの制御メーカーにわたって調査されました。サードパーティコントロールメーカーは、独立したメーカーのコントロールと機器固有のコントロールについてさらに調査されました。

エンドユーザー別だと、臨床検査室、病院、および調査および学術機関にわたって調査されました。

地域別だと、南北アメリカ、アジア太平洋、欧州、中東・アフリカにわたって調査されました。

COVID-19の累積的影響:

COVID-19は、ほぼすべての業界に影響を与えた比類のない世界的な公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されます。私たちの進行中の調査は、調査フレームワークを増幅して、基礎となるCOVID-19の問題と今後の潜在的な道筋を確実に含めるようにしています。調査は消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場の力のダイナミクス、および政府の重要な介入を考慮したCOVID-19に関する洞察を提供しています。更新された調査は、市場へのCOVID-19の影響を考慮して、洞察、分析、推定、および予測を提供します。

レポートは、次の指針に関する洞察を提供します。

  • 1.市場浸透:主要なプレーヤーにより提供される市場に関する包括的な情報
  • 2.市場開発:収益性の高い新興市場に関する詳細な情報と市場分析
  • 3.市場の多様化:新製品の発売、未開発の地域、最近の開発、および投資に関する詳細情報
  • 4.競争力のある評価とインテリジェンス:主要企業の市場シェア、戦略、製品、製造能力の徹底的な評価を提供します
  • 5.製品開発とイノベーション:将来のテクノロジー、R&D活動、および新製品開発に関する洞察

レポートは次のような質問に答えます。

1.世界の体外診断品質管理市場の市場規模と予測はどのくらいですか?

2.予測期間中に世界の体外診断品質管理市場を形成するCOVID-19の阻害要因と影響は何ですか?

3.世界の体外診断品質管理市場の予測期間中に投資する製品/セグメント/用途/領域はどれですか?

4.世界の体外診断品質管理市場における機会の競争戦略ウィンドウは何ですか?

5.世界の体外診断品質管理市場動向技術動向と規制の枠組みは何ですか?

6.世界のな体外診断品質管理市場に参入するのに適していると考えられるモードと戦略的動きは何ですか?

当レポートでは、体外診断品質管理市場を調査し、市場概要、市場の成長要因および阻害要因の分析、タイプ別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画を作成する
    • 実行:調査を実施する
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • ディストリビューター別の見通し
  • 提供別の見通し
  • 用途別の見通し
  • エンドユーザー別の見通し
  • 地域別の見通し
  • 競合他社別の見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 提供別の世界の体外診断品質管理市場

  • イントロダクション
  • データ管理ソリューション
  • 品質保証サービス
  • 品質管理製品
    • 尿ベースのコントロール
    • 全血ベースのコントロール
    • 全血ベースのコントロール

第7章 用途別の世界の体外診断品質管理市場

  • イントロダクション
  • 臨床化学
  • 凝固または止血
  • 血液学
  • 免疫化学
  • 微生物学
  • 分子診断

第8章 ディストリビューター別の世界の体外診断品質管理市場

  • イントロダクション
  • OEM
  • サードパーティコントロールメーカー
    • 独立した製造業者の管理
    • 機器固有のコントロール

第9章 エンドユーザー別の世界の体外診断品質管理市場

  • イントロダクション
  • 臨床検査室
  • 病院
  • 調査&学術機関

第10章 南北アメリカの体外診断品質管理市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の体外診断品質管理市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第12章 欧州・中東・アフリカの体外診断品質管理市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第14章 企業のユーザビリティプロファイル

  • Abbott Laboratories Inc.
  • Bio-Rad Laboratories, Inc.
  • Helena Laboratories
  • Ortho Clinical Diagnostics, Inc.
  • Randox Laboratories Ltd
  • Roche Diagnostics
  • Seracare Life Sciences, Inc.
  • Sero as
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.

第15章 付録

  • ディスカッションガイド
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2026
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 VS 2026 (%)
  • FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2026
  • FIGURE 27. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 36. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 38. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, 2018-2026 (USD MILLION)
  • FIGURE 41. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 43. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2026 (USD MILLION)
  • FIGURE 45. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 47. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 48. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 49. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 50. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 51. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2026
  • FIGURE 53. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2026 (USD MILLION)
  • FIGURE 54. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 55. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 56. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2026 (USD MILLION)
  • FIGURE 58. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 59. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 60. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 62. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. CALIFORNIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. FLORIDA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. ILLINOIS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. NEW YORK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. OHIO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. PENNSYLVANIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. TEXAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 75. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 76. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 77. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 84. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 85. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 86. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 87. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 88. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 89. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 90. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 91. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 92. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 93. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 94. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 95. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 96. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 97. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 98. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 99. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: FPNV POSITIONING MATRIX
  • FIGURE 100. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 101. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 102. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. CALIFORNIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. CALIFORNIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. CALIFORNIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. CALIFORNIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. FLORIDA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. FLORIDA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. FLORIDA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. FLORIDA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ILLINOIS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. ILLINOIS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. ILLINOIS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. ILLINOIS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. NEW YORK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. NEW YORK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. NEW YORK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. NEW YORK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. OHIO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. OHIO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. OHIO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. OHIO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. PENNSYLVANIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. PENNSYLVANIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. PENNSYLVANIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. PENNSYLVANIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. TEXAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. TEXAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. TEXAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. TEXAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 144. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 145. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 146. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 147. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 148. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 149. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 150. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 151. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 152. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 153. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 154. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 155. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 156. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 157. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 158. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 159. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 160. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 161. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 162. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 163. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 164. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 165. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 166. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SCORES
  • TABLE 167. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: BUSINESS STRATEGY
  • TABLE 168. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: PRODUCT SATISFACTION
  • TABLE 169. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: RANKING
  • TABLE 170. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 171. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY COMPANY, 2020
  • TABLE 172. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MERGER & ACQUISITION
  • TABLE 173. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 174. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 175. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: INVESTMENT & FUNDING
  • TABLE 176. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 177. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: LICENSE & PRICING
  • TABLE 178. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: CONTACT DETAILS
目次
Product Code: MRR-43127F7279E2

The Global In-Vitro Diagnostics Quality Control Market size was estimated at USD 1,095.99 Million in 2020 and expected to reach USD 1,169.47 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.04% to reach USD 1,648.75 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the In-Vitro Diagnostics Quality Control to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Offering, the In-Vitro Diagnostics Quality Control Market was studied across Data Management Solutions, Quality Assurance Services, and Quality Control Products. The Quality Control Products is further studied across Urine-Based Controls, Whole-Blood-Based Controls, and Whole-Blood-Based Controls.

Based on Distributor, the In-Vitro Diagnostics Quality Control Market was studied across OEM and Third-Party Control Manufacturers. The Third-Party Control Manufacturers is further studied across Independent Manufacturer Controls and Instrument-Specific Controls.

Based on Application, the In-Vitro Diagnostics Quality Control Market was studied across Clinical Chemistry, Coagulation or Hemostasis, Hematology, Immunochemistry, Microbiology, and Molecular Diagnostics.

Based on End User, the In-Vitro Diagnostics Quality Control Market was studied across Clinical Laboratories, Hospitals, and Research & Academic Institutes.

Based on Geography, the In-Vitro Diagnostics Quality Control Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the In-Vitro Diagnostics Quality Control Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global In-Vitro Diagnostics Quality Control Market, including Abbott Laboratories Inc., Bio-Rad Laboratories, Inc., Helena Laboratories, Ortho Clinical Diagnostics, Inc., Randox Laboratories Ltd, Roche Diagnostics, Seracare Life Sciences, Inc., Sero as, Technopath Clinical Diagnostics, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global In-Vitro Diagnostics Quality Control Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global In-Vitro Diagnostics Quality Control Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In-Vitro Diagnostics Quality Control Market?
  • 4. What is the competitive strategic window for opportunities in the Global In-Vitro Diagnostics Quality Control Market?
  • 5. What are the technology trends and regulatory frameworks in the Global In-Vitro Diagnostics Quality Control Market?
  • 6. What is the market share of the leading vendors in the Global In-Vitro Diagnostics Quality Control Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global In-Vitro Diagnostics Quality Control Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Distributor Outlook
  • 3.4. Offering Outlook
  • 3.5. Application Outlook
  • 3.6. End User Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Geriatric population and prevalence of chronic and infectious diseases
      • 5.1.1.2. Rise in the number of accredited clinical laboratories and adoption of third-party quality controls
      • 5.1.1.3. Demand for advanced diagnostics for sensitive reports and accurate diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of IVD quality control services
      • 5.1.2.2. Unfavorable reimbursement
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in the demand for multi-analyte controls
      • 5.1.3.2. Growth opportunities in emerging countries
    • 5.1.4. Challenges
      • 5.1.4.1. Limited regulations for clinical laboratory accreditation in several emerging countries
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. In-Vitro Diagnostics Quality Control Market, by Offering

  • 6.1. Introduction
  • 6.2. Data Management Solutions
  • 6.3. Quality Assurance Services
  • 6.4. Quality Control Products
    • 6.4.1. Urine-Based Controls
    • 6.4.2. Whole-Blood-Based Controls
    • 6.4.3. Whole-Blood-Based Controls

7. In-Vitro Diagnostics Quality Control Market, by Distributor

  • 7.1. Introduction
  • 7.2. OEM
  • 7.3. Third-Party Control Manufacturers
    • 7.3.1. Independent Manufacturer Controls
    • 7.3.2. Instrument-Specific Controls

8. In-Vitro Diagnostics Quality Control Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Chemistry
  • 8.3. Coagulation or Hemostasis
  • 8.4. Hematology
  • 8.5. Immunochemistry
  • 8.6. Microbiology
  • 8.7. Molecular Diagnostics

9. In-Vitro Diagnostics Quality Control Market, by End User

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Hospitals
  • 9.4. Research & Academic Institutes

10. Americas In-Vitro Diagnostics Quality Control Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific In-Vitro Diagnostics Quality Control Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa In-Vitro Diagnostics Quality Control Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Abbott Laboratories Inc.
  • 14.2. Bio-Rad Laboratories, Inc.
  • 14.3. Helena Laboratories
  • 14.4. Ortho Clinical Diagnostics, Inc.
  • 14.5. Randox Laboratories Ltd
  • 14.6. Roche Diagnostics
  • 14.7. Seracare Life Sciences, Inc.
  • 14.8. Sero as
  • 14.9. Technopath Clinical Diagnostics
  • 14.10. Thermo Fisher Scientific Inc.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.